Immunotherapy delays recurrence for stage III and IV ovarian cancers

Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the cancer’s return.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1Cjuj7u